Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
Workday
WDAY
5
Lantheus
LNTH
US OptionsDetailed Quotes
ARAY250516C2000
- 0.05
- 0.000.00%
15min DelayClose Apr 30 13:36 ET
0.05High0.03Low
0.03Open0.05Pre Close2 Volume12 Open Interest2.00Strike Price8.00Turnover136.77%IV32.26%PremiumMay 16, 2025Expiry Date0.00Intrinsic Value100Multiplier15DDays to Expiry0.05Extrinsic Value100Contract SizeAmericanOptions Type0.2253Delta0.6852Gamma31.00Leverage Ratio-0.0043Theta0.0001Rho6.98Eff Leverage0.0010Vega
Accuray Newsroom
Accuray Outlines Q4 Revenue Guidance With $10M-$15M Impact From China Tariffs
Accuray: Due to Tariff Announcements and Estimated Impact to Pdt Volume, Adjusting Rev Guidance for FY25 >ARAY
Accuray GAAP EPS of -$0.01 Beats by $0.03, Revenue of $113.2M Beats by $11.67M
Accuray Reports Strong Q3 2025 Financial Performance
Express News | Accuray Lowers FY2025 Sales Guidance From $463.00M-$475.00M to $452.00M-$460.00M Vs $468.30M Est
Accuray | 8-K: Accuray Reports Fiscal 2025 Third Quarter Financial Results
Express News | Accuray Reports Fiscal 2025 Third Quarter Financial Results
Express News | Accuray Incorporated Q3 Income From Operations USD 1.047 Million
Express News | Accuray Incorporated Q3 Gross Profit USD 31.627 Million
Express News | Accuray Incorporated Q3 Operating Expenses USD 30.58 Million
Express News | Accuray Incorporated Q3 Basic EPS USD -0.01
Accuray 3Q Rev $113.2M >ARAY
Accuray 3Q Loss/Shr 1c >ARAY
Accuray Q3 25 Earnings Conference Call At 4:30 PM ET
Here Are the Major Earnings After the Close Today
Calendar of U.S. Earnings Expected in the Week Ahead
Insights Ahead: Accuray's Quarterly Earnings
Goldman Sachs: The Q1 performance of U.S. pharmaceutical stocks is reassuring, and the Industry sentiment is slightly becoming more positive.
Goldman Sachs stated that amid cautious sentiment from investors towards the USA pharmaceutical sector before the Earnings Reports season, the performance of USA pharmaceutical companies that have reported results so far for the first quarter has not been worse than expected, and in some cases, it has even exceeded expectations.
Earnings Preview: Accuray to Report Financial Results Post-market on April 30
Accuray to Report Third Quarter Fiscal 2025 Financial Results on April 30, 2025
Market Insights
Discussing
Trade war escalates: What’s next for Chinese stocks?
🎙️Discussion 1. China-EU EV negotiations kick off recently. How do you think the negotiations will impact the performance of related stocks
Moo Earnings
Feb 17 19:21
Alibaba Q4 FY2024 Earnings Preview: Predict & Win Big! 🚀
Discussing
FOMC holds rates amid heightened uncertainty: Where will US stocks head next?
🎙️Discussion 1. With the Fed highlighting "elevated uncertainty", are you prioritizing rate projections or near-term economic data for ma
Moo Live
Mar 20 02:25
FOMC Press Conference, March 19, 2025
U.S Tech Companies U.S Tech Companies
U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data. U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data.
Unlock Now
